UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000045535
Receipt No. R000051991
Scientific Title Multicenter study of acinar cell carcinoma in Japan
Date of disclosure of the study information 2021/09/21
Last modified on 2021/09/21 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Multicenter study of acinar cell carcinoma in Japan
Acronym Multicenter study of acinar cell carcinoma
Scientific Title Multicenter study of acinar cell carcinoma in Japan
Scientific Title:Acronym Multicenter study of acinar cell carcinoma
Region
Japan

Condition
Condition acinar cell carcinoma
Classification by specialty
Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to examine the clinic-pathologic features of patients with acinar cell carcinoma
Basic objectives2 Others
Basic objectives -Others To reveal the pathological grading of acinar cell carcinoma
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To reveal the clinic-pathologic features of patients with acinar cell carcinoma
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria The patients with acinar cell carcinoma diagnosed histologically by resection or EUS-FNA between January 2000 and December 2020
Key exclusion criteria The cases without component of acinar cell carcinoma
The cases without histlogical diagnosis
Target sample size 200

Research contact person
Name of lead principal investigator
1st name Atsushi
Middle name
Last name Kanno
Organization Jichi Medical University
Division name Department of Medicine, Division of Gastroenterology
Zip code 329-0498
Address 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan
TEL 0285-58-7348
Email atsushih@jichi.ac.jp

Public contact
Name of contact person
1st name Atsushi
Middle name
Last name Kanno
Organization Jichi Medical University
Division name Department of Medicine, Division of Gastroenterology
Zip code 329-0498
Address 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan
TEL 0285-58-7348
Homepage URL
Email atsushih@jichi.ac.jp

Sponsor
Institute Japan Pancreas Society
Institute
Department

Funding Source
Organization Japan Pancreas Society
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Support Center for Clinical Investigation, Jichi Medical University
Address 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan
Tel 0285-58-8933
Email rinri@jichi.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 09 Month 21 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2021 Year 04 Month 08 Day
Date of IRB
2021 Year 05 Month 07 Day
Anticipated trial start date
2021 Year 10 Month 01 Day
Last follow-up date
2026 Year 09 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information This was a retrospective, observational study that examined the clinic-pathologic features of patients with acinar cell carcinoma diagnosed between January 2000 and December 2020.

Management information
Registered date
2021 Year 09 Month 21 Day
Last modified on
2021 Year 09 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051991